Michael Murphy

Feb 20, 2025 | onlinelibrary.wiley.com | Michael Murphy |Celldex Therapeutics |Laura Vitale |Thomas O'Neill

1 Introduction Biologic-based therapies targeting cytokine pathways have resulted in marked clinical benefit in many inflammatory and autoimmune disorders [1]. However, many of these diseases are heterogeneous in nature and are generally driven by a multitude of cell types, pathways, or mechanisms, which inherently limits the effectiveness of most therapies directed at single targets.

Nov 25, 2024 | moneyshow.com | Michael Murphy

In the near term, I expect inflation to continue to slowly fall – in large part because I still think a brief, shallow recession is coming. But two years from now, I think inflation will be higher as Trump tries to undo many of the policies that he believes weakened the country even as they dampened inflation. I like Palantir Technologies Inc. (PLTR) here, notes Michael Murphy, editor of New World Investor.

Nov 11, 2024 | moneyshow.com | Michael Murphy

Stocks jumped after Trump’s election, with the S&P 500 and Nasdaq Composite hitting record levels. Investors expect lower taxes and deregulation, but higher inflation and interest rates. Meanwhile, I want to talk about Corning Inc. (GLW) and a recent European regulatory issue, writes Michael Murphy, editor of New World Investor. Many investors, including me, thought the presidential race would be much closer and the process could be drawn out before a victor was declared.

Oct 14, 2024 | moneyshow.com | Michael Murphy

One complaint with young people today is that “social media is destroying them” in various ways. In this environment, wouldn’t it be smart for a social media CEO to say his company is definitely not social media? It’s really about connecting family and friends in a positive, uplifting way? Welcome to Snap Inc. (SNAP), highlights Michael Murphy, editor of New World Investor. Snap bills itself as a camera company, but what they really offer is an image- and video-based social media experience.

Sep 11, 2024 | moneyshow.com | Michael Murphy

There is an asymmetric opportunity available – relatively low risk for a relatively large reward. It’s relatively low risk since it’s cheap because Wall Street hates it and it’s a lower-risk legal structure. It’s a relatively large reward because – well – Wall Street is wrong. I’m talking about funds like the iShares US Real Estate ETF (IYR), counsels Michael Murphy, editor of New World Investor. Wall Street thinks commercial real estate is falling apart.